Unjha Formulations - Quaterly Results

Unjha Formulations Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 531762 | NSE:

04 Feb 2025 Evaluate

A decrease of about -32.16% in the sales to Rs. 37.62 millions was observed for the quarter ended December 2024. The sales stood at Rs. 55.45 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 2.25 millions from Rs. 3.89 millions, a decline of -42.16% on QoQ basis.Operating Profit reported a sharp decline to 2.50 millions from 4.09 millions in the corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202412	202312	% Var	202412	202312	% Var	202403	202303	% Var
Sales	37.62	55.45	-32.16	115.23	140.70	-18.10	185.08	131.85	40.37
Other Income	0.11	-0.02	-650.00	0.11	-0.02	-650.00	0.00	0.00	0.00
PBIDT	2.50	4.09	-38.88	8.86	5.19	70.71	5.89	4.63	27.21
Interest	0.02	0.01	100.00	0.05	0.06	-16.67	0.56	0.58	-3.45
PBDT	2.48	4.08	-39.22	8.81	5.13	71.73	5.33	4.05	31.60
Depreciation	0.23	0.19	21.05	0.67	0.58	15.52	0.81	0.77	5.19
PBT	2.25	3.89	-42.16	8.14	4.55	78.90	4.52	3.28	37.80
TAX	0.00	0.00	0.00	0.00	0.00	0.00	1.74	0.47	270.21
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.00	0.00
PAT	2.25	3.89	-42.16	8.14	4.55	78.90	2.78	2.81	-1.07
Equity	44.81	44.81	0.00	44.81	44.81	0.00	44.81	44.81	0.00
PBIDTM(%)	6.65	7.38	-9.91	7.69	3.69	108.45	3.18	3.51	-9.37